ESC 365 - Association of coagulation markers and antiphospholipid antibodies with ischemic and bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention

ESC Professional Premium Access

Association of coagulation markers and antiphospholipid antibodies with ischemic and bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention

Session: Coronary artery disease - Different aspects

Topic: Thrombosis, Platelets, and Coagulation

Speaker: Ms V. Anfang (Freiburg, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Ms Viktoria Anfang

Heart Center, University of Freiburg, Freiburg (Germany)

0 follower

5 more presentations in this session

Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes

Speaker: Doctor L. Esposito (Salerno, IT)

Epicardial adipose tissue, infarct size, microvascular obstruction and ventricular remodelling after ST-segment elevation myocardial infarction

Speaker: Doctor A. Aimo (Pisa, IT)

Prognostic implication of residual inflammatory risk according to disease status in patients treated with percutaneous coronary intervention

Speaker: Doctor H. Song (Gwangmyeong, KR)

Platelet extracellular vesicles are superior to cardiac troponin to diagnose acute coronary syndrome with short symptom duration: LEMONADE trial

Speaker: Doctor A. Gasecka (Warsaw, PL)

Multivessel spontaneous coronary artery dissection: clinical features, angiographic findings, management, and outcomes

Speaker: Doctor J. Salamanca Viloria (Madrid, ES)

Access the full session

Coronary artery disease - Different aspects

Speakers: Ms V. Anfang, Doctor L. Esposito, Doctor A. Aimo, Doctor H. Song, Doctor A. Gasecka...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources